Prove-it™ Herpes test has achieved CE-mark for In Vitro Diagnostics (IVD) of central nervous system infections caused by herpesviruses. The PCR- and microarray-based test enables simultaneous identification of seven human herpesviruses from cerebrospinal fluid specimen in less than three hours. The rapid and comprehensive results provided by Prove-it™ Herpes are crucial to the clinicians for targeting antiviral treatment correctly. Furthermore, the coverage of the assay eliminates the need for multiple tests and thereby saves time and cuts cost in hospitals.

Link to the original article.